BIRCHWOOD PHARMA LTDActive

Company number 07673770Private limited companyIncorporated 2011

Key figures

£458,138-0.2%
Net assets 2024/25
-11.7%
Average annual change 2019/20–2024/25
0250 k500 k750 k1 m2019/202020/212021/222022/232023/242024/25

BIRCHWOOD PHARMA LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year-28,620-272,397-67,078-25,682-832
Cash at bank and in hand818,406553,411486,111460,072459,355
Total assets826,872567,496486,452460,291459,514
Total liabilities2,74515,7661,8001,3211,376
Net assets / total equity824,127551,730484,652458,970458,138
Average number of employees22222
Average pay (per year)———6,500—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: BIRCHWOOD PHARMA LTD

Company

BIRCHWOOD PHARMA LTD is a private limited company registered with Companies House under company number 07673770. It was incorporated on 17 Jun 2011. Its status is active. The registered office is in Dartford (DA2). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Loss for the year was £832. Net assets were £458,138, down 0.2% on the previous year. Cash at bank and in hand was £459,355. Total assets were £459,514 and total liabilities £1,376. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 4 Aug 2027.